A. Bardet

759 total citations
19 papers, 115 citations indexed

About

A. Bardet is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Family Practice. According to data from OpenAlex, A. Bardet has authored 19 papers receiving a total of 115 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 4 papers in Radiology, Nuclear Medicine and Imaging and 3 papers in Family Practice. Recurrent topics in A. Bardet's work include Radiomics and Machine Learning in Medical Imaging (4 papers), Lung Cancer Diagnosis and Treatment (4 papers) and Lung Cancer Treatments and Mutations (4 papers). A. Bardet is often cited by papers focused on Radiomics and Machine Learning in Medical Imaging (4 papers), Lung Cancer Diagnosis and Treatment (4 papers) and Lung Cancer Treatments and Mutations (4 papers). A. Bardet collaborates with scholars based in France, United Kingdom and Switzerland. A. Bardet's co-authors include Karine Peignaux, Corinne Faivre‐Finn, Gérard Zalcman, J. Madelaine, A. Lavolé, Éric Pichon, N. Pourel, D. Antoni, Oliver Riesterer and A. Paumier and has published in prestigious journals such as Journal of Clinical Oncology, European Heart Journal and British Journal of Cancer.

In The Last Decade

A. Bardet

15 papers receiving 113 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Bardet France 5 67 46 18 14 10 19 115
Ashlyn S. Everett United States 5 29 0.4× 41 0.9× 18 1.0× 9 0.6× 8 0.8× 16 99
Gabriele Infante Italy 9 60 0.9× 79 1.7× 10 0.6× 47 3.4× 10 1.0× 26 186
Tatiana Conrad Canada 7 113 1.7× 46 1.0× 24 1.3× 17 1.2× 6 0.6× 24 139
Lalit Mohan Sharma India 8 58 0.9× 33 0.7× 15 0.8× 20 1.4× 4 0.4× 28 145
Sushmita Rath India 8 40 0.6× 83 1.8× 16 0.9× 33 2.4× 6 0.6× 25 143
Christina Henson United States 9 49 0.7× 68 1.5× 30 1.7× 31 2.2× 4 0.4× 39 205
Khaled Zaza Canada 6 55 0.8× 30 0.7× 18 1.0× 35 2.5× 3 0.3× 8 109
Isao Numata Japan 8 132 2.0× 43 0.9× 13 0.7× 44 3.1× 4 0.4× 20 231
Brian C. Boulmay United States 8 39 0.6× 55 1.2× 20 1.1× 16 1.1× 5 0.5× 28 126
Fidelma Cahill United Kingdom 8 28 0.4× 60 1.3× 8 0.4× 30 2.1× 8 0.8× 18 132

Countries citing papers authored by A. Bardet

Since Specialization
Citations

This map shows the geographic impact of A. Bardet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Bardet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Bardet more than expected).

Fields of papers citing papers by A. Bardet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Bardet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Bardet. The network helps show where A. Bardet may publish in the future.

Co-authorship network of co-authors of A. Bardet

This figure shows the co-authorship network connecting the top 25 collaborators of A. Bardet. A scholar is included among the top collaborators of A. Bardet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Bardet. A. Bardet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Nanchen, David, Lâle Tokgözoğlu, J. Komen, et al.. (2024). Contemporary LDL-cholesterol management in male and female patients at high-cardiovascular risk: results from the European observational SANTORINI study. European Heart Journal. 45(Supplement_1).
2.
Meglio, Antonio Di, Julie Havas, Martina Pagliuca, et al.. (2024). Patterns of depressive symptoms among survivors of early-stage breast cancer (BC).. Journal of Clinical Oncology. 42(16_suppl). 12009–12009.
3.
Giudici, Fabiola, Barbara Pistilli, Inês Vaz-Luís, et al.. (2023). Insights adjusting for non-adherence in randomized clinical trials: a reanalysis of an adjuvant trial of tamoxifen duration in early breast cancer. British Journal of Cancer. 129(9). 1516–1523. 2 indexed citations
4.
Michels, Judith, Y. Menu, Corinne Balleyguier, et al.. (2023). Bevacizumab exposure and tumor response in patients with platinum resistant epithelial ovarian cancer.. Journal of Clinical Oncology. 41(16_suppl). 3093–3093. 1 indexed citations
5.
Bardet, A., Michel Ducreux, Sophie Laurent, et al.. (2022). Development of a Decision-Aid Form (DAF) for the stratification of care in a French comprehensive cancer center, a tool to support identification of care goals. Annals of Palliative Medicine. 11(6). 1876–1887. 3 indexed citations
6.
Rassy, Elie, A. Bardet, Suzette Delaloge, et al.. (2022). Association of Adherence to Endocrine Therapy Among Patients With Breast Cancer and Potential Drug-Drug Interactions. JAMA Network Open. 5(12). e2244849–e2244849. 4 indexed citations
7.
Thomas, P., John Edwards, Ramón Rami–Porta, et al.. (2022). The Lung ART adjuvant radiotherapy phase 3 randomized trial: Impact of quality of resection in stage IIIAN2 patients.. Journal of Clinical Oncology. 40(16_suppl). 8522–8522.
8.
Charles, Cécile, A. Bardet, Linda Cambon, et al.. (2021). Delivering adapted physical activity by videoconference to patients with fatigue under immune checkpoint inhibitors: Lessons learned from the PACTIMe-FEAS feasibility study. Journal of Telemedicine and Telecare. 29(9). 716–724. 15 indexed citations
9.
10.
11.
Pistilli, Barbara, Arlindo R. Ferreira, Angélo Paci, et al.. (2020). 167MO Longitudinal evaluation of serum assessed non-adherence to tamoxifen (TAM) among premenopausal patients (pts) in the prospective multicenter CANTO cohort. Annals of Oncology. 31. S308–S308. 1 indexed citations
12.
Pourel, N., D. Lerouge, Corinne Faivre‐Finn, et al.. (2020). PH-0280: Quality of surgery and RT in stage IIIN2 NSCLC: Insights from the Lung Adjuvant Radiotherapy trial. Radiotherapy and Oncology. 152. S140–S141.
13.
Rossoni, Caroline, A. Bardet, Birgit Geoerger, & Xavier Paolettí. (2019). Sequential or combined designs for Phase I/II clinical trials? A simulation study. Clinical Trials. 16(6). 635–644. 7 indexed citations
14.
Solal‐Céligny, Philippe, et al.. (2017). A retrospective study on the management of patients with rituximab refractory follicular lymphoma. British Journal of Haematology. 180(2). 217–223. 6 indexed citations
15.
Chaoui, Driss, Sylvain Choquet, Laurence Sanhès, et al.. (2017). Relapsed chronic lymphocytic leukemia retreated with rituximab: interim results of the PERLE study. Leukemia & lymphoma. 58(6). 1366–1375. 3 indexed citations
16.
Meyer, Néva P., Brigitte Dréno, Célèste Lebbé, et al.. (2016). Cobimetinib plus vemurafenib to treat unresectable or metastatic melanoma: Data from the French temporary authorization for use. Annals of Oncology. 27. vi390–vi390. 1 indexed citations
17.
Bardet, A.. (2009). Les chambres fermées en psychiatrie: poursuivre le débat pour dépasser les conflits. Schweizer Archiv für Neurologie und Psychiatrie. 160(1). 4–11. 2 indexed citations
18.
Zheng, Hong, Xavier Favereau, Yves Guérin, et al.. (2000). Conservative management for an extensive type A aortic dissection complicating coronary angioplasty.. PubMed. 12(6). 320–3. 6 indexed citations
19.
Bardet, A., et al.. (1973). [Study of systolic intervals in hyperthyroidism without cardiac complications].. PubMed. 66(7). 877–89. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ashlyn S. Everett Breakdown of academic impact, for papers by Gabriele Infante Breakdown of academic impact, for papers by Tatiana Conrad Breakdown of academic impact, for papers by Lalit Mohan Sharma Breakdown of academic impact, for papers by Sushmita Rath Breakdown of academic impact, for papers by Christina Henson Breakdown of academic impact, for papers by Khaled Zaza Breakdown of academic impact, for papers by Isao Numata Breakdown of academic impact, for papers by Brian C. Boulmay Breakdown of academic impact, for papers by Fidelma Cahill
Rankless by CCL
2026